Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Ankylosing Spondylitis Drug Market 2018, Forecast to 2023

Table of Contents

1 Market Overview

• 1.1 Ankylosing Spondylitis Drug Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Cimzia
  • 1.2.2 Enbrel
  • 1.2.3 Humira
  • 1.2.4 Remicade
  • 1.2.5 Simponi
  • 1.2.6 Others
• 1.3 Market Analysis by Applications
  • 1.3.1 Hospitals
  • 1.3.2 Clinics
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2013-2023)
    • 1.4.1.2 Canada Market States and Outlook (2013-2023)
    • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2013-2023)
    • 1.4.2.2 France Market States and Outlook (2013-2023)
    • 1.4.2.3 UK Market States and Outlook (2013-2023)
    • 1.4.2.4 Russia Market States and Outlook (2013-2023)
    • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2013-2023)
    • 1.4.3.2 Japan Market States and Outlook (2013-2023)
    • 1.4.3.3 Korea Market States and Outlook (2013-2023)
    • 1.4.3.4 India Market States and Outlook (2013-2023)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
    • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
    • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Amgen
  • 2.1.1 Business Overview
    • 2.1.1.1 Amgen Description
    • 2.1.1.2 Amgen Headquarter, Main Business and Finance Overview
  • 2.1.2 Amgen Ankylosing Spondylitis Drug Product Introduction
    • 2.1.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
    • 2.1.2.2 Ankylosing Spondylitis Drug Product Information
  • 2.1.3 Amgen Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.1.3.1 Amgen Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.1.3.2 Global Amgen Ankylosing Spondylitis Drug Market Share in 2017
• 2.2 Wyeth
  • 2.2.1 Business Overview
    • 2.2.1.1 Wyeth Description
    • 2.2.1.2 Wyeth Headquarter, Main Business and Finance Overview
  • 2.2.2 Wyeth Ankylosing Spondylitis Drug Product Introduction
    • 2.2.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
    • 2.2.2.2 Ankylosing Spondylitis Drug Product Information
  • 2.2.3 Wyeth Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2.3.1 Wyeth Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2.3.2 Global Wyeth Ankylosing Spondylitis Drug Market Share in 2017
• 2.3 Takeda
  • 2.3.1 Business Overview
    • 2.3.1.1 Takeda Description
    • 2.3.1.2 Takeda Headquarter, Main Business and Finance Overview
  • 2.3.2 Takeda Ankylosing Spondylitis Drug Product Introduction
    • 2.3.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
    • 2.3.2.2 Ankylosing Spondylitis Drug Product Information
  • 2.3.3 Takeda Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3.3.1 Takeda Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3.3.2 Global Takeda Ankylosing Spondylitis Drug Market Share in 2017
• 2.4 Centocor
  • 2.4.1 Business Overview
    • 2.4.1.1 Centocor Description
    • 2.4.1.2 Centocor Headquarter, Main Business and Finance Overview
  • 2.4.2 Centocor Ankylosing Spondylitis Drug Product Introduction
    • 2.4.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
    • 2.4.2.2 Ankylosing Spondylitis Drug Product Information
  • 2.4.3 Centocor Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4.3.1 Centocor Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4.3.2 Global Centocor Ankylosing Spondylitis Drug Market Share in 2017
• 2.5 Schering-Plough
  • 2.5.1 Business Overview
    • 2.5.1.1 Schering-Plough Description
    • 2.5.1.2 Schering-Plough Headquarter, Main Business and Finance Overview
  • 2.5.2 Schering-Plough Ankylosing Spondylitis Drug Product Introduction
    • 2.5.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
    • 2.5.2.2 Ankylosing Spondylitis Drug Product Information
  • 2.5.3 Schering-Plough Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5.3.1 Schering-Plough Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5.3.2 Global Schering-Plough Ankylosing Spondylitis Drug Market Share in 2017
• 2.6 Mitsubishi Tanabe
  • 2.6.1 Business Overview
    • 2.6.1.1 Mitsubishi Tanabe Description
    • 2.6.1.2 Mitsubishi Tanabe Headquarter, Main Business and Finance Overview
  • 2.6.2 Mitsubishi Tanabe Ankylosing Spondylitis Drug Product Introduction
    • 2.6.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
    • 2.6.2.2 Ankylosing Spondylitis Drug Product Information
  • 2.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6.3.1 Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6.3.2 Global Mitsubishi Tanabe Ankylosing Spondylitis Drug Market Share in 2017
• 2.7 Abbott
  • 2.7.1 Business Overview
    • 2.7.1.1 Abbott Description
    • 2.7.1.2 Abbott Headquarter, Main Business and Finance Overview
  • 2.7.2 Abbott Ankylosing Spondylitis Drug Product Introduction
    • 2.7.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
    • 2.7.2.2 Ankylosing Spondylitis Drug Product Information
  • 2.7.3 Abbott Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7.3.1 Abbott Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7.3.2 Global Abbott Ankylosing Spondylitis Drug Market Share in 2017
• 2.8 Eisai
  • 2.8.1 Business Overview
    • 2.8.1.1 Eisai Description
    • 2.8.1.2 Eisai Headquarter, Main Business and Finance Overview
  • 2.8.2 Eisai Ankylosing Spondylitis Drug Product Introduction
    • 2.8.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
    • 2.8.2.2 Ankylosing Spondylitis Drug Product Information
  • 2.8.3 Eisai Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8.3.1 Eisai Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8.3.2 Global Eisai Ankylosing Spondylitis Drug Market Share in 2017
• 2.9 Pfizer
  • 2.9.1 Business Overview
    • 2.9.1.1 Pfizer Description
    • 2.9.1.2 Pfizer Headquarter, Main Business and Finance Overview
  • 2.9.2 Pfizer Ankylosing Spondylitis Drug Product Introduction
    • 2.9.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
    • 2.9.2.2 Ankylosing Spondylitis Drug Product Information
  • 2.9.3 Pfizer Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.9.3.1 Pfizer Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.9.3.2 Global Pfizer Ankylosing Spondylitis Drug Market Share in 2017
• 2.10 Johnson & Johnson
  • 2.10.1 Business Overview
    • 2.10.1.1 Johnson & Johnson Description
    • 2.10.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
  • 2.10.2 Johnson & Johnson Ankylosing Spondylitis Drug Product Introduction
    • 2.10.2.1 Ankylosing Spondylitis Drug Production Bases, Sales Regions and Major Competitors
    • 2.10.2.2 Ankylosing Spondylitis Drug Product Information
  • 2.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.10.3.1 Johnson & Johnson Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.10.3.2 Global Johnson & Johnson Ankylosing Spondylitis Drug Market Share in 2017

  3 Global Ankylosing Spondylitis Drug Market Competition, by Manufacturer

  • 3.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Manufacturer (2016-2017)
  • 3.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Manufacturer (2016-2017)
  • 3.3 Global Ankylosing Spondylitis Drug Price by Manufacturer (2016-2017)
  • 3.4 Market Concentration Rate
    • 3.4.1 Top 3 Ankylosing Spondylitis Drug Manufacturer Market Share in 2017
    • 3.4.2 Top 5 Ankylosing Spondylitis Drug Manufacturer Market Share in 2017
  • 3.5 Market Competition Trend

  4 Global Ankylosing Spondylitis Drug Market Analysis by Regions

  • 4.1 Global Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Ankylosing Spondylitis Drug Sales by Regions (2013-2018)
    • 4.1.2 Global Ankylosing Spondylitis Drug Revenue by Regions (2013-2018)
  • 4.2 North America Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2013-2018)
  • 4.3 Europe Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2013-2018)
  • 4.5 South America Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2013-2018)

  5 North America Ankylosing Spondylitis Drug by Countries, Type, Application and Manufacturers

  • 5.1 North America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Ankylosing Spondylitis Drug Sales by Countries (2013-2018)
    • 5.1.2 North America Ankylosing Spondylitis Drug Revenue by Countries (2013-2018)
    • 5.1.3 United States Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 5.1.4 Canada Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 5.1.5 Mexico Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
  • 5.2 North America Ankylosing Spondylitis Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
    • 5.2.1 North America Ankylosing Spondylitis Drug Sales by Manufacturers (2016-2017)
    • 5.2.2 North America Ankylosing Spondylitis Drug Revenue by Manufacturers (2016-2017)
  • 5.3 North America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2013-2018)
    • 5.3.1 North America Ankylosing Spondylitis Drug Sales and Sales Share by Type (2013-2018)
    • 5.3.2 North America Ankylosing Spondylitis Drug Revenue and Revenue Share by Type (2013-2018)
  • 5.4 North America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Application (2013-2018)
    • 5.4.1 North America Ankylosing Spondylitis Drug Sales and Sales Share by Application (2013-2018)
    • 5.4.2 North America Ankylosing Spondylitis Drug Revenue and Revenue Share by Application (2013-2018)

  6 Europe Ankylosing Spondylitis Drug by Countries, Type, Application and Manufacturers

  • 6.1 Europe Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Ankylosing Spondylitis Drug Sales by Countries (2013-2018)
    • 6.1.2 Europe Ankylosing Spondylitis Drug Revenue by Countries (2013-2018)
    • 6.1.3 Germany Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 6.1.4 UK Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 6.1.5 France Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 6.1.6 Russia Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 6.1.7 Italy Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
  • 6.2 Europe Ankylosing Spondylitis Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
    • 6.2.1 Europe Ankylosing Spondylitis Drug Sales by Manufacturers (2016-2017)
    • 6.2.2 Europe Ankylosing Spondylitis Drug Revenue by Manufacturers (2016-2017)
  • 6.3 Europe Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2013-2018)
    • 6.3.1 Europe Ankylosing Spondylitis Drug Sales and Sales Share by Type (2013-2018)
    • 6.3.2 Europe Ankylosing Spondylitis Drug Revenue and Revenue Share by Type (2013-2018)
  • 6.4 Europe Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Application (2013-2018)
    • 6.4.1 Europe Ankylosing Spondylitis Drug Sales and Sales Share by Application (2013-2018)
    • 6.4.2 Europe Ankylosing Spondylitis Drug Revenue and Revenue Share by Application (2013-2018)

  7 Asia-Pacific Ankylosing Spondylitis Drug by Countries, Type, Application and Manufacturers

  • 7.1 Asia-Pacific Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Ankylosing Spondylitis Drug Sales by Countries (2013-2018)
    • 7.1.2 Asia-Pacific Ankylosing Spondylitis Drug Revenue by Countries (2013-2018)
    • 7.1.3 China Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 7.1.4 Japan Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 7.1.5 Korea Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 7.1.6 India Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 7.1.7 Southeast Asia Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
  • 7.2 Asia-Pacific Ankylosing Spondylitis Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
    • 7.2.1 Asia-Pacific Ankylosing Spondylitis Drug Sales by Manufacturers (2016-2017)
    • 7.2.2 Asia-Pacific Ankylosing Spondylitis Drug Revenue by Manufacturers (2016-2017)
  • 7.3 Asia-Pacific Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2013-2018)
    • 7.3.1 Asia-Pacific Ankylosing Spondylitis Drug Sales and Sales Share by Type (2013-2018)
    • 7.3.2 Asia-Pacific Ankylosing Spondylitis Drug Revenue and Revenue Share by Type (2013-2018)
  • 7.4 Asia-Pacific Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Application (2013-2018)
    • 7.4.1 Asia-Pacific Ankylosing Spondylitis Drug Sales and Sales Share by Application (2013-2018)
    • 7.4.2 Asia-Pacific Ankylosing Spondylitis Drug Revenue and Revenue Share by Application (2013-2018)

  8 South America Ankylosing Spondylitis Drug by Countries, Type, Application and Manufacturers

  • 8.1 South America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Ankylosing Spondylitis Drug Sales by Countries (2013-2018)
    • 8.1.2 South America Ankylosing Spondylitis Drug Revenue by Countries (2013-2018)
    • 8.1.3 Brazil Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 8.1.4 Argentina Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 8.1.5 Colombia Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
  • 8.2 South America Ankylosing Spondylitis Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
    • 8.2.1 South America Ankylosing Spondylitis Drug Sales by Manufacturers (2016-2017)
    • 8.2.2 South America Ankylosing Spondylitis Drug Revenue by Manufacturers (2016-2017)
  • 8.3 South America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2013-2018)
    • 8.3.1 South America Ankylosing Spondylitis Drug Sales and Sales Share by Type (2013-2018)
    • 8.3.2 South America Ankylosing Spondylitis Drug Revenue and Revenue Share by Type (2013-2018)
  • 8.4 South America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Application (2013-2018)
    • 8.4.1 South America Ankylosing Spondylitis Drug Sales and Sales Share by Application (2013-2018)
    • 8.4.2 South America Ankylosing Spondylitis Drug Revenue and Revenue Share by Application (2013-2018)

  9 Middle East and Africa Ankylosing Spondylitis Drug by Countries, Type, Application and Manufacturers

  • 9.1 Middle East and Africa Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Ankylosing Spondylitis Drug Sales by Countries (2013-2018)
    • 9.1.2 Middle East and Africa Ankylosing Spondylitis Drug Revenue by Countries (2013-2018)
    • 9.1.3 Saudi Arabia Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 9.1.4 UAE Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 9.1.5 Egypt Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 9.1.6 Nigeria Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
    • 9.1.7 South Africa Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
  • 9.2 Middle East and Africa Ankylosing Spondylitis Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
    • 9.2.1 Middle East and Africa Ankylosing Spondylitis Drug Sales by Manufacturers (2016-2017)
    • 9.2.2 Middle East and Africa Ankylosing Spondylitis Drug Revenue by Manufacturers (2016-2017)
  • 9.3 Middle East and Africa Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2013-2018)
    • 9.3.1 Middle East and Africa Ankylosing Spondylitis Drug Sales and Sales Share by Type (2013-2018)
    • 9.3.1 Middle East and Africa Ankylosing Spondylitis Drug Revenue and Revenue Share by Type (2013-2018)
  • 9.4 Middle East and Africa Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Application (2013-2018)
    • 9.4.1 Middle East and Africa Ankylosing Spondylitis Drug Sales and Sales Share by Application (2013-2018)
    • 9.4.2 Middle East and Africa Ankylosing Spondylitis Drug Revenue and Revenue Share by Application (2013-2018)

  10 Global Ankylosing Spondylitis Drug Market Segment by Type

  • 10.1 Global Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Type (2013-2018)
    • 10.1.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Type (2013-2018)
  • 10.2 Cimzia Sales Growth and Price
    • 10.2.1 Global Cimzia Sales Growth (2013-2018)
    • 10.2.2 Global Cimzia Price (2013-2018)
  • 10.3 Enbrel Sales Growth and Price
    • 10.3.1 Global Enbrel Sales Growth (2013-2018)
    • 10.3.2 Global Enbrel Price (2013-2018)
  • 10.4 Humira Sales Growth and Price
    • 10.4.1 Global Humira Sales Growth (2013-2018)
    • 10.4.2 Global Humira Price (2013-2018)
  • 10.5 Remicade Sales Growth and Price
    • 10.5.1 Global Remicade Sales Growth (2013-2018)
    • 10.5.2 Global Remicade Price (2013-2018)
  • 10.6 Simponi Sales Growth and Price
    • 10.6.1 Global Simponi Sales Growth (2013-2018)
    • 10.6.2 Global Simponi Price (2013-2018)
  • 10.7 Others Sales Growth and Price
    • 10.7.1 Global Others Sales Growth (2013-2018)
    • 10.7.2 Global Others Price (2013-2018)

  11 Global Ankylosing Spondylitis Drug Market Segment by Application

  • 11.1 Global Ankylosing Spondylitis Drug Sales Market Share by Application (2013-2018)
  • 11.2 Hospitals Sales Growth (2013-2018)
  • 11.3 Clinics Sales Growth (2013-2018)

  12 Ankylosing Spondylitis Drug Market Forecast (2018-2023)

  • 12.1 Global Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2018-2023)
  • 12.2 Ankylosing Spondylitis Drug Market Forecast by Regions (2018-2023)
    • 12.2.1 North America Ankylosing Spondylitis Drug Market Forecast (2018-2023)
    • 12.2.2 Europe Ankylosing Spondylitis Drug Market Forecast (2018-2023)
    • 12.2.3 Asia-Pacific Ankylosing Spondylitis Drug Market Forecast (2018-2023)
    • 12.2.4 South America Ankylosing Spondylitis Drug Market Forecast (2018-2023)
    • 12.2.5 Middle East and Africa Ankylosing Spondylitis Drug Market Forecast (2018-2023)
  • 12.3 Ankylosing Spondylitis Drug Market Forecast by Type (2018-2023)
    • 12.3.1 Global Ankylosing Spondylitis Drug Sales Forecast by Type (2018-2023)
    • 12.3.2 Global Ankylosing Spondylitis Drug Market Share Forecast by Type (2018-2023)
  • 12.4 Ankylosing Spondylitis Drug Market Forecast by Application (2018-2023)
    • 12.4.1 Global Ankylosing Spondylitis Drug Sales Forecast by Application (2018-2023)
    • 12.4.2 Global Ankylosing Spondylitis Drug Market Share Forecast by Application (2018-2023)

  13 Sales Channel, Distributors, Traders and Dealers

  • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
    • 13.1.2 Indirect Marketing
    • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers

  14 Research Findings and Conclusion

  15 Appendix

  • 15.1 Methodology